Crown Laboratories Acquires Aesthetics Eclipse’s Aesthetics Portfolio
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
Enrollment is complete in a phase 2 trial investigating the use of pure PDGF as an adjunctive therapy for complex surgical wounds following skin cancer excision.